Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe
organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most …

Lupus nephritis (LN) is one of the most common manifestations of systemic lupus
erythematosus (SLE), affecting approximately 40% of patients with lupus. It represents a …

New clinical, laboratory and experimental insights, since the 1999 publication of the
Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been …

Objective: Systemic lupus erythematosus (SLE) is a complex disease with variable
presentations, course and prognosis. We sought to develop evidence-based …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
occurrence of venous and/or arterial thrombosis and pregnancy morbidity in the presence of …

Objectives To develop recommendations for monitoring patients with systemic lupus
erythematosus (SLE) in clinical practice and observational studies and to develop a …

Systemic lupus erythematosus may present with renal manifestations that frequently are
difficult to categorize and lupus nephritis is an important predictor of poor outcome. The type …

The objective of this study was to identify the factors associated with important clinical
outcomes in a case-control study of 213 patients with lupus nephritis. Included were 47 …

The objective of this work was to conduct a systematic literature review (SLR) and meta-
analysis (MA) to evaluate the relative risk (RR) of venous thromboembolism (VTE) events …

Kidney damage is a well-recognized complication of the antiphospholipid syndrome (APS),
either primary or systemic lupus erythematosus (SLE)-associated APS. Kidney involvement …